PLS3 mutations in X-linked osteoporosis with fractures

F.S. van Dijk, M.C. Zillikens, D. Micha, M. Riessland, C.L.M. Marcelis, C.E. de Die-Smulders, J. Milbradt, A.A. Franken, A.J. Harsevoort, K.D. Lichtenbelt, H.E. Pruijs, M.E. Rubio-Gozalbo, R. Zwertbroek, Y. Moutaouakil, J. Egthuijsen, M. Hammerschmidt, R. Bijman, C.M. Semeins, A.D. Bakker, V. EvertsJ. Klein-Nulend, N. Campos-Obando, A. Hofman, G.J. te Meerman, A.J.M.H. Verkerk, A.G. Uitterlinden, A. Maugeri, E.A. Sistermans, Q. Waisfisz, H. Meijers-Heijboer, B. Wirth, M.E.H. Simon, G. Pals

Research output: Contribution to journalArticleAcademicpeer-review

160 Citations (Scopus)

Abstract

Plastin 3 (PLS3), a protein involved in the formation of filamentous actin (F-actin) bundles, appears to be important in human bone health, on the basis of pathogenic variants in PLS3 in five families with X-linked osteoporosis and osteoporotic fractures that we report here. The bone-regulatory properties of PLS3 were supported by in vivo analyses in zebrafish. Furthermore, in an additional five families (described in less detail) referred for diagnosis or ruling out of osteogenesis imperfecta type I, a rare variant (rs140121121) in PLS3 was found. This variant was also associated with a risk of fracture among elderly heterozygous women that was two times as high as that among noncarriers, which indicates that genetic variation in PLS3 is a novel etiologic factor involved in common, multi-factorial osteoporosis.
Original languageEnglish
Pages (from-to)1529-1536
JournalThe New England journal of medicine
Volume369
Issue number16
DOIs
Publication statusPublished - 2013

Cite this